Arcutis Biotherapeutics Inc Topline Data Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Arcutis Biotherapeutics Topline Data Call. (Operator Instructions)
I would now like to turn the call over to [Eric McIntyre], you may begin.
Thank you, Kevin. Good morning, everyone, and thank you for starting your Mondays off with us. We're incredibly excited here to be with you to discuss our positive top line results for the STRATUM pivotal Phase III study evaluating roflumilast foam as a potential topical treatment for seborrheic dermatitis. Today's webcast and posted presentation can be found under the Events and Presentations tab of our Investors section of our website.
And then, of course, before we begin, I'd like to remind you all that the safe harbor rules govern or remarks today as well as any forward-looking statements that we make during this call. These statements are subject to any risks and uncertainties that could cause actual results to differ materially.
With that, I'm extremely pleased to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
